• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 16 Results
Document Number k030213
 
 1 
 2 
 > 
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas pro integrated solutions, cobas c 703  {ONLINE DAT Cannabinoids II} 
CR260281 K030213 Cannabinoids (THC) Toxicology / TDM MODERATE 04/28/2026
Roche Diagnostics, cobas c 303  {ONLINE DAT Cannabinoids II} 
CR220440 k030213 Cannabinoids (THC) Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics cobas c 503 analytical unit  
CR200050 K030213 Cannabinoids (THC) Toxicology / TDM MODERATE 02/21/2020
Roche Diagnostics cobas c 502 Analyzer  
K100853 K030213 Cannabinoids (THC) Toxicology / TDM MODERATE 01/10/2011
Olympus AU5400  {Roche Diagnostics Online DAT Cannabinoids II} 
K030213 K030213 Cannabinoids (THC) Toxicology / TDM MODERATE 04/14/2010
Roche Diagnostics cobas c 311 Analyzer  
K030213 K030213 Cannabinoids (THC) Toxicology / TDM MODERATE 08/22/2007
Roche Diagnostics Cobas Integra 400 Plus  
K030213 K030213 Cannabinoids (THC) Toxicology / TDM MODERATE 04/07/2004
Roche Diagnostics Cobas Integra 400  
K030213 K030213 Cannabinoids (THC) Toxicology / TDM MODERATE 04/07/2004
Roche Diagnostics Cobas Integra 800  
K030213 K030213 Cannabinoids (THC) Toxicology / TDM MODERATE 04/07/2004
Roche Diagnostics Cobas Integra 700  
K030213 K030213 Cannabinoids (THC) Toxicology / TDM MODERATE 04/07/2004

-
-